Venture Capital 102 @ HMS: Featuring Frank David, MD, PhD, Founder and Managing Director at Pharmagellan

by Health Care Club


Wed, 14 Feb 2018

5:00 PM – 6:30 PM

Add to Calendar

Cannon Room, Building C, Harvard Medical School




What is venture capital in the life sciences? Join us for a discussion of valuations and finance in biotech followed by a Q&A session. Biotech forecasts and valuation models are essential when evaluating publicly traded biotech companies, licensing deals, venture investments, and even your own biotech startup!

WHEN: Wednesday, February 14, at 5 – 6:30 pm

WHERE: Cannon Room, Building C, Harvard Medical School

Dinner will be provided. RSVP at: https://goo.gl/forms/RvLoz5ASGCtLvpfh2

For questions, please email harvardbiotechclub@gmail.com

Harvard Biotech Club

Share with friends

Hosted By

Health Care Club